| Product Name | Lusutrombopag |
|---|---|
| CAS | 1110766-97-6 |
| Formula | C29H32Cl2N2O5S |
| MW | 591.55 |
| MDL | MFCD28502075 |
| Appearance | White to off-white powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 5 mg | 3-5days | ¥1600.00 | Visible after login | |
| 10 mg | 3-5days | ¥2400.00 | Visible after login |
| Product Name | Lusutrombopag |
|---|---|
| CAS | 1110766-97-6 |
| Formula | C29H32Cl2N2O5S |
| MW | 591.55 |
| MDL | MFCD28502075 |
| Appearance | White to off-white powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Lusutrombopag (formerly known as S888711; S-888711;trade name:Mulpleta) is a novel orally bioavailable, small molecule agonist of thrombopoietin (TPO) receptor.
Lusutrombopag: First Global Approval.
PMID: 26666417 DOI: 10.1007/s40265-015-0525-4